Get Premium to unlock powerful stock data
NAS:KZR (USA)  
Kezar Life Sciences Inc logo

Kezar Life Sciences Inc

$ 5.78 -0.26 (-4.3%) 10:08 PM EST
P/E:
At Loss
P/B:
1.48
Market Cap:
$ 349.20M
Enterprise V:
$ 136.12M
Volume:
3.05M
Avg Vol (2M):
1.36M
Also Trade In:
Volume:
3.05M
Market Cap $:
349.20M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.36M
Enterprise Value $:
136.12M
PB Ratio:
1.48
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Kezar Life Sciences Inc
NAICS : 325412 SIC : 2834
4000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Description
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.
Name Current Vs Industry Vs History
Cash-To-Debt 17.56
Equity-to-Asset 0.92
Debt-to-Equity 0.06
Debt-to-EBITDA -0.25
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 62.5
9-Day RSI 57.53
14-Day RSI 47.67
6-1 Month Momentum % -66.79
12-1 Month Momentum % -9.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 35.25
Quick Ratio 35.25
Cash Ratio 34.77

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -43.3
Name Current Vs Industry Vs History
ROE % -35.19
ROA % -32.3
ROIC % -661.52
ROC (Joel Greenblatt) % -957.69
ROCE % -33.4

Financials (Next Earnings Date:2022-08-12 Est.)

KZR's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:KZR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.04
Beta 0.31
Volatility % 123.28
14-Day RSI 47.67
14-Day ATR ($) 0.483976
20-Day SMA ($) 5.1945
12-1 Month Momentum % -9.66
52-Week Range ($) 4.305 - 18.55
Shares Outstanding (Mil) 60.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kezar Life Sciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More